Skip to main content

Henry Schein Value Stock - Dividend - Research Selection

Henry schein

ISIN: US8064071025 , WKN: 897961

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners.  We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics.  We believe that we have a strong brand identity due to our more than 84 years of experience distributing health care products.

 

We are headquartered in Melville, New York, employ more than 21,000 people (of which more than 10,500 are based outside the United States) and have operations or affiliates in 33 countries, including the United States, Australia, Austria, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Japan, Luxembourg, Malaysia, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand and the United Kingdom.

 

We offer a comprehensive selection of products and services and value-added solutions for operating efficient practices and delivering high quality care.  We operate through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private brand products in stock, as well as more than 180,000 additional products available as special order items.  We also offer our customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

 

We have established over 4.5 million square feet of space in 62 strategically located distribution centers around the world to enable us to better serve our customers and increase our operating efficiency.  This infrastructure, together with broad product and service offerings at competitive prices, and a strong commitment to customer service, enables us to be a single source of supply for our customers’ needs.  Our infrastructure also allows us to provide convenient ordering and rapid, accurate and complete order fulfillment.

 

We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and value-added services.  These segments offer different products and services to the same customer base. 

 

The health care distribution reportable segment aggregates our global dental, animal health and medical operating segments.  This segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.  Our global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions.  Our global animal health group serves animal health practices and clinics.  Our global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. 

 

Our technology and value-added services group provides software, technology and other value-added services to health care practitioners.  Our technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics.  Our value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

 

Source: www.sec.gov

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Henry Schein, Inc. (HSIC): A Bull Case Theory

2025-09-17
We came across a bullish thesis on Henry Schein, Inc. on Show me the incentives…’s Substack. In this article, we will summarize the bulls’ thesis on HSIC. Henry Schein, Inc.’s share was trading at $67.41 as of September 10th. HSIC’s trailing and forward P/E were 21.68 and 12.95 respectively according to Yahoo Finance. Henry Schein (HSIC), the […]

BofA lists 13 SMID cap stocks that could rebound

2025-09-11
Investing.com -- Small and mid-cap (SMID) stocks are beginning to attract renewed interest after a long stretch of underperformance, according to Bank of America strategists, with signs of profit recovery and optimism around Federal Reserve cuts helping sentiment.

Henry Schein (HSIC) Expands SolutionsHub With Colaborate And Increases US$750 Million Buyback

2025-09-10
On September 9, 2025, Henry Schein (HSIC) announced two major developments: the expansion of its SolutionsHub™ with Colaborate to enhance U.S. medical laboratories' efficiency, and a $750 million increase in its equity buyback plan. Over the last month, HSIC shares rose 3% amidst these initiatives, aligning them with a general upward market trend. These strategic announcements likely reinforced shareholder confidence during a period where broader market indices, including the S&P 500 and...

Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript

2025-09-10
Discover insights from Henry Schein's 2025 Baird Healthcare Conference, including market

Henry Schein Announces $750 Million Share Repurchase Plan

2025-09-09
MELVILLE, N.Y., September 09, 2025--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock.

Henry Schein Medical Expands SolutionsHub with Colaborate

2025-09-09
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories. Together, Henry Schein and Colaborate will empower clinical laboratories across the U.S. to maintain compliance, enhance operational efficiency, and increase financial sustainability.

Henry Schein, Inc. (HSIC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

2025-09-04
Discover Henry Schein's growth strategies, cost savings, and technology innovations

Does The Market Have A Low Tolerance For Henry Schein, Inc.'s (NASDAQ:HSIC) Mixed Fundamentals?

2025-09-04
With its stock down 4.7% over the past three months, it is easy to disregard Henry Schein (NASDAQ:HSIC). It seems that...

Dental Equipment & Technology Stocks Q2 Recap: Benchmarking Henry Schein (NASDAQ:HSIC)

2025-08-29
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).

Henry Schein Inc. stock underperforms Monday when compared to competitors

2025-08-25
Henry Schein Inc. stock underperforms Monday when compared to competitors